Glioblastoma
📧 Sign up to get email alerts when something new happens for Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Study to Evaluate the Safety, Tolerability, Immunogenicity and Preliminary Efficacy of ITI-1001 In Patients With Newly Diagnosed Glioblastoma (GBM) [Phase 1]
Phase 1 clinical trial updating the safety, tolerability, immunogenicity, and preliminary efficacy of ITI-1001 for newly diagnosed glioblast…
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas [Phase 1, Phase 2]
Clinical trial updating a Phase 1/2 study of liposomal curcumin with radiotherapy and temozolomide for newly diagnosed glioblastoma; recruit…
-
CLINICAL_TRIALS research · 2024-11-26Clinical Trial Update: Function and Composition of Regulatory B Cells in Participants With Glioblastoma
This document provides an update on a clinical trial investigating regulatory B cells in adults with glioblastoma; the study status is termi…
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: Patient-derived Glioma Stem Cell Organoids
A clinical trial update describing a study using patient-derived glioma stem cell organoids for glioblastoma, with the trial currently not r…
-
CLINICAL_TRIALS research · 2024-11-14Clinical Trial Update: Optimizing Cytokine-Induced Killer Cells in Glioblastoma Patients
A clinical trial registry entry describing optimization of cytokine-induced killer cells for glioblastoma, currently not recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-11-05Clinical Trial Update: TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating the combination of tumor-infiltrating lymphocyte (TIL) therapy with pembrolizumab for advanced brai…
-
CLINICAL_TRIALS research · 2024-10-31Clinical Trial Update: A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70 [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study investigating the combination of radiation therapy and temozolomide for glioblastoma …
-
CLINICAL_TRIALS research · 2024-10-29Clinical Trial Update: XS005 Injection Combined With Stupp Regimen for Adjuvant Chemotherapy in Subjects With Primary Glioblastoma(GBM) [Phase 1, Phase 2]
A Phase 1/Phase 2 trial evaluating XS005 injections with the Stupp regimen for adjuvant chemotherapy in patients with primary glioblastoma h…
-
CLINICAL_TRIALS research · 2024-10-24Clinical Trial Update: Artificial Intelligence-Guided Radiotherapy Planning for Glioblastoma
This entry reports a clinical trial evaluating artificial intelligence-guided radiotherapy planning for glioblastoma. The study status is NO…
-
CLINICAL_TRIALS research · 2024-10-17Clinical Trial Update: Lonafarnib and Temozolomide in Treating Patients with Glioblastoma Multiforme That is Recurrent or Did Not Respond to Previous Treatment with Temozolomide [Phase 1]
Phase 1 trial update evaluating lonafarnib in combination with temozolomide for recurrent glioblastoma multiforme and related gliomas.
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies [Phase 1, Phase 2]
This clinical trial update describes ongoing Phase 1/2 evaluation of NGM707 as a monotherapy and in combination with pembrolizumab in advanc…
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: Extensive Resection of Malignant Brain Tumors Using Advanced Imaging Techniques [NA]
The study evaluates extensive surgical resection of malignant brain tumors using advanced imaging techniques and is currently recruiting.
-
CLINICAL_TRIALS research · 2024-09-27Clinical Trial Update: The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the rGBM [Phase 1]
Clinical trial update on the safety and efficacy of SNC-109 CAR-T Cells Therapy for recurrent glioblastoma multiforme, currently in Phase 1 …
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Adjuvant Dendritic Cell-immunotherapy Plus Temozolomide in Glioblastoma Patients [Phase 1, Phase 2]
Phase 1/2 trial update evaluating adjuvant dendritic cell immunotherapy with temozolomide in glioblastoma patients, sponsored by University …
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma [NA]
A clinical trial update indicates Northwell Health is recruiting for a study testing a surgical tissue flap to bypass the blood-brain barrie…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM [Phase 3]
Phase 3 clinical trial evaluating repeated superselective intraarterial infusion of bevacizumab with temozolomide and radiation versus temoz…
-
CLINICAL_TRIALS research · 2024-08-30Clinical Trial Update: Niraparib and Temozolomide in Patients Glioblastoma [Phase 1, Phase 2]
Early-phase clinical trial evaluating the combination of niraparib and temozolomide in patients with glioblastoma; the study is not yet recr…
-
CLINICAL_TRIALS research · 2024-07-31Clinical Trial Update: Surgically Induced Neurological Deficits in Glioblastomas (SIND Study)
The SIND study investigates surgically induced neurological deficits in glioblastoma and is sponsored by Cambridge University Hospitals NHS …
-
CLINICAL_TRIALS research · 2024-07-29Clinical Trial Update: Targeted Survivin DC Cell Injection for the Treatment of GBM [Phase 1]
Phase 1 clinical trial of a targeted survivin dendritic cell injection for glioblastoma. The study is sponsored by Beijing Tricision Biother…
-
CLINICAL_TRIALS research · 2024-07-24Clinical Trial Update: Research on the Safety and Efficacy of Blocking Dural Blood Supply in Glioblastoma Patients [NA]
This clinical trial update describes research evaluating blocking the dural blood supply in glioblastoma patients to assess safety and effic…
-
CLINICAL_TRIALS research · 2024-07-08Clinical Trial Update: Expectations and Needs of a Glioblastoma Caregiver
A completed study investigating the expectations and needs of caregivers for patients with glioblastoma.
-
CLINICAL_TRIALS research · 2024-06-28Clinical Trial Update: FET-PET-Guided Management of Pseudoprogression in Glioblastoma [NA]
A clinical trial studying FET-PET-guided management of pseudoprogression in glioblastoma, with recruitment not yet started.
-
CLINICAL_TRIALS research · 2024-06-27Clinical Trial Update: Study of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated Radiation ThErapy and TEmozolomide in Newly Diagnosed GLioblastoma (GBM) Patients [Phase 3]
A Phase 3 trial is planned to evaluate adding liposomal transcrocetin to hypofractionated radiotherapy and temozolomide in newly diagnosed g…
-
CLINICAL_TRIALS research · 2024-06-24Clinical Trial Update: Preoperative Preradiotherapy TTFields [NA]
Clinical trial update on preoperative preradiotherapy Tumor Treating Fields (TTFields) for Glioblastoma. The study is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-06-06Clinical Trial Update: MRI Hypoxia Study for Glioblastoma Multiforme (GBM) Radiation Therapy
A clinical trial update for an MRI hypoxia imaging study in glioblastoma patients undergoing radiation therapy, sponsored by the University …